Manufacturing

Benefits of Technologies Facilitate Adoption of Single-use Systems

Single-use systems hold key benefits for biomanufacturers, despite certain limitations.

Safeguarding Biologics— Blending Engineering Ingenuity and Managerial Excellence

Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.

Digitalization of Biomanufacturing: A Status Update

Digitalization of bioprocessing is slowly bringing benefits to the biopharma industry.

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

March 21, 2023

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Sandoz to Build New Biologics Production Facility in Slovenia

March 17, 2023

Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

March 17, 2023

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Webcasts

Driving Environmental Sustainability in the Biopharmaceutical Industry

March 10, 2023

Webinar Date/Time: Wednesday, March 29th 2023 7am PDT | 10am EST | 4pm CEST

Catalent Expands UpTempo AAV Platform

March 09, 2023

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Webcasts